Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

CVS Group Plc

Healthcare GB CVSG

1233.0GBX
-1.0(0.08%)

Last update at 2026-06-03T15:39:00Z

Day Range

1214.001240.00
LowHigh

52 Week Range

955.351636.61
LowHigh

Fundamentals

  • Previous Close 1234.00
  • Market Cap820.83M
  • Volume436657
  • P/E Ratio50.87
  • Dividend Yield0.72%
  • EBITDA90.40M
  • Revenue TTM692.80M
  • Revenue Per Share TTM9.66
  • Gross Profit TTM 299.60M
  • Diluted EPS TTM0.23

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 32.60M 38.20M 53.90M 36.00M 33.10M
Minority interest - -0.20000M - - -
Net income 19.30M 6.20M 41.90M 25.70M 19.30M
Selling general administrative - 227.10M 200.00M 196.30M 181.80M
Selling and marketing expenses - - - - -
Gross profit 259.70M 277.90M 262.30M 239.10M 221.90M
Reconciled depreciation - 58.50M 50.40M 47.60M 48.10M
Ebit 49.80M 49.90M 61.30M 42.50M 40.10M
Ebitda 114.30M 108.40M 111.70M 90.10M 88.20M
Depreciation and amortization 64.50M 58.50M 50.40M 47.60M 48.10M
Non operating income net other - - - - -
Operating income 71.80M 50.80M 62.30M 42.80M 40.10M
Other operating expenses 601.40M 596.50M 546.00M 511.40M 470.00M
Interest expense 17.20M 12.60M 7.40M 6.80M 7.00M
Tax provision - 11.80M 12.00M 10.30M 13.80M
Interest income - - - - 7.00M
Net interest income - -12.60000M -8.40000M -6.80000M -7.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 13.50M 11.80M 12.00M 10.30M 13.80M
Total revenue 673.20M 647.30M 608.30M 554.20M 510.10M
Total operating expenses 187.90M 227.10M 200.00M 196.30M 181.80M
Cost of revenue 413.50M 369.40M 346.00M 315.10M 288.20M
Total other income expense net -39.20000M -12.60000M -8.40000M -6.80000M -7.00000M
Discontinued operations - - - - -
Net income from continuing ops - 26.40M 41.90M 25.70M 19.30M
Net income applicable to common shares - - 41.90M 25.70M 19.30M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 696.20M 690.00M 572.30M 518.20M 484.50M
Intangible assets 105.90M 113.20M 93.60M 95.90M 114.50M
Earning assets - - - - -
Other current assets 13.40M 24.80M 52.70M 52.70M 48.20M
Total liab 394.50M 429.50M 315.30M 300.80M 293.40M
Total stockholder equity 299.80M 260.40M 257.00M 217.40M 191.10M
Deferred long term liab - - - - -
Other current liab 57.20M 17.90M -78.40000M -78.40000M 32.70M
Common stock 0.10M 0.10M 0.10M 0.10M 0.10M
Capital stock - 0.10M 0.10M 0.10M 0.10M
Retained earnings 198.30M 211.20M 209.10M 171.10M 149.10M
Other liab - - 24.80M 20.00M 20.80M
Good will 231.70M 221.70M 162.50M 120.60M 113.90M
Other assets - - - 2.30M -
Cash 16.10M 16.50M 21.50M 49.00M 33.70M
Cash and equivalents - - - - -
Total current liabilities 123.30M 118.10M 105.10M 101.40M 98.50M
Current deferred revenue 1.60M 2.30M 128.70M 83.80M -28.80000M
Net debt 232.70M 271.30M 177.60M 139.80M 149.00M
Short term debt 15.20M 27.80M 13.30M 9.40M 8.60M
Short long term debt - - - - 0.00000M
Short long term debt total 248.80M 287.80M 199.10M 188.80M 182.70M
Other stockholder equity 109.10M 47.60M 47.80M 46.20M 41.90M
Property plant equipment - - 204.40M 171.40M 154.60M
Total current assets 135.40M 128.60M 111.80M 127.90M 101.40M
Long term investments - - - - -
Net tangible assets - - 0.50M 0.90M -37.30000M
Short term investments - - - - 1.20M
Net receivables 77.40M 55.50M 28.90M 52.70M 39.60M
Long term debt - 181.30M 92.20M -84.30000M 83.90M
Inventory 28.50M 31.80M 28.40M 26.20M 19.50M
Accounts payable 49.30M 50.10M 41.50M 86.60M 86.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -7.70000M 1.50M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - 0.10M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.90M 2.40M 2.40M 0.10M
Deferred long term asset charges - - - - -
Non current assets total 560.80M 561.40M 460.50M 390.30M 383.10M
Capital lease obligations - 106.50M 106.90M -104.50000M 98.80M
Long term debt total - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -140.50000M -99.90000M -12.40000M -35.40000M
Change to liabilities - - -0.80000M -0.10000M -5.20000M
Total cashflows from investing activities -22.70000M -140.50000M -99.90000M -45.10000M -35.40000M
Net borrowings - 88.70M -4.40000M -12.80000M -14.10000M
Total cash from financing activities -59.20000M 68.30M -12.10000M -15.10000M -12.60000M
Change to operating activities - - -1.40000M -1.80000M -1.10000M
Net income 18.90M 6.40M 41.90M 25.70M 19.30M
Change in cash -0.40000M -5.00000M -27.50000M 15.30M 12.20M
Begin period cash flow 16.50M 21.50M 49.00M 33.70M 21.50M
End period cash flow 16.10M 16.50M 21.50M 49.00M 33.70M
Total cash from operating activities 82.10M 67.80M 84.50M 75.50M 60.20M
Issuance of capital stock - 2.40M 2.10M 2.30M 1.50M
Depreciation 64.50M 58.50M 50.40M 47.60M 48.10M
Other cashflows from investing activities 42.30M -3.60000M - - -18.80000M
Dividends paid 5.70M 5.40M 5.00M 4.60M 3.90M
Change to inventory 2.90M -3.00000M -1.80000M -6.60000M -0.40000M
Change to account receivables -9.90000M -17.40000M -4.60000M -3.20000M -3.40000M
Sale purchase of stock - -0.90000M -1.20000M 4.60M 3.90M
Other cashflows from financing activities -16.60000M -16.50000M -7.20000M -12.70000M -13.00000M
Change to netincome - - -0.20000M 13.90M 2.90M
Capital expenditures 26.40M 43.10M 45.70M 24.50M 16.60M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.70000M -10.50000M -8.60000M -11.70000M -10.10000M
Stock based compensation - 2.40M 1.70M 2.30M 2.20M
Other non cash items 3.90M 11.80M 10.70M 6.80M 7.00M
Free cash flow 55.70M 24.70M 38.80M 51.00M 43.60M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CVSG
CVS Group Plc		 -1.0 0.08% 1233.00 50.87 12.08 1.18 2.69 1.52 9.51
SPI
Spire Healthcare Group Plc		 -0.5 0.23% 217.00 37.06 13.91 0.38 0.78 1.18 7.70
OHGR
One Health Group Plc		 - -% 251.50 24.09 18.15 1.06 2.75 0.75 10.53
KNB
Kanabo Group PLC		 -0.2228 99.02% 0.0022 - - 1.25 0.24 0.07 -2.2141

Reports Covered

Stock Research & News

View All

Profile

CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products, as well as an online dispensary. In addition, the company provides veterinary instrumentation supply and property development services. The company was founded in 1999 and is headquartered in Diss, the United Kingdom.

CVS Group Plc

CVS House, Diss, United Kingdom, IP22 4ER

Key Executives

Name Title Year Born
Mr. Richard William Mark Fairman F.C.A. CEO & Director 1967
Mr. Robin Jay Alfonso F.C.A. CFO & Director 1979
Mr. Benjamin David Jacklin M.A., MA, VetMB, MVetMed, DipECVS, MRCVS COO & Director 1984
Mr. Gordon Palmer Head of IT NA
Mr. Enrico Tizzano Chief Technology Officer NA
Ms. Helen Finney Group HR Director NA
Mr. Paul Higgs Chief Veterinary Officer NA
Ms. Jenny Farrer Group Company Sec. 1977
Mr. Zak Leavold Commercial Director NA
Mr. Robert Dawson Small Animal Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.